CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse Other stock markets 21:10:00 18/06/2025 BST			5-day change	1st Jan Change
145.29 ^USD	+0.17%		-3.85%	-21.29%

06-09	Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM
06-04	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM

Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM

Published on 14/05/2025 at 13:00, updated on 14/05/2025 at 16:40

Presenter Speech
Michael Ryskin (Analysts)

And joining us for our next session is Charles River Labs. Thanks so much. We're joined by Birgit Girshick.

Format will be a

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10:00 AM	06-09
Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10:30 AM	06-04
Charles River Laboratories International to Seek Strategic M&A	06-03	CI
Charles River Laboratories, CHDI Foundation Extend Collaboration	05-28	MT
Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation	05-28	RE
Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027 - SEC Filing	05-23	RE
Declaration of Voting Results by Charles River Laboratories International	05-23	CI
Trump's Tariff Blitz Roils Markets, Targets EU and Apple	05-23
Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188	05-23	MT
Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…	05-23
Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08:40 AM	05-14
TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105	05-14	MT
Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184	05-09	MT
UBS Cuts Price Target on Charles River Laboratories International to $150 From $185, Keeps Neutral Rating	05-08	MT
Barclays Adjusts Price Target on Charles River Laboratories International to $155 From $145, Maintains Equalweight Rating	05-08	MT
Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $180 From $140, Maintains Buy Rating	05-08	MT
London Calling: Markets Jump	05-08
Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating	05-08	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $145 From $165, Maintains Neutral Rating	05-08	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $150 From $175, Maintains Neutral Rating	05-08	MT
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $180 From $140, Maintains Buy Rating	05-08	MT
Evercore ISI Upgrades Charles River Laboratories International to Outperform From In Line, Adjusts PT to $170 From $235	05-08	MT
Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...	05-08
Equity Markets Close Higher as Fed Decides to Keep Fund Rates Unchanged	05-07	MT
Sector Update: Health Care Stocks Rise Late Afternoon	05-07	MT